CHIMIN HEALTH MANAGEMENT CO., LTD. Financials Chimin Health Management Co., Ltd.
Equities
603222
CNE100002193
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.18 CNY | +1.15% |
|
+4.04% | -22.85% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 4,346 | 17,600 | 4,326 | 6,270 | 4,174 | 4,255 |
| Enterprise Value (EV) 1 | 4,815 | 18,048 | 4,803 | 6,586 | 4,125 | 4,374 |
| P/E ratio | 136 x | 250 x | 675 x | 41.8 x | 125 x | -66.8 x |
| Yield | 0.15% | 0.09% | - | 0.49% | 0.23% | - |
| Capitalization / Revenue | 6.23 x | 22.8 x | 4.93 x | 5.71 x | 4.99 x | 4.76 x |
| EV / Revenue | 6.9 x | 23.4 x | 5.47 x | 6 x | 4.93 x | 4.89 x |
| EV / EBITDA | 43.3 x | 116 x | 28.3 x | 23 x | 25.9 x | 29.9 x |
| EV / FCF | -30.6 x | -105 x | 617 x | -18.4 x | -142 x | 183 x |
| FCF Yield | -3.26% | -0.95% | 0.16% | -5.45% | -0.7% | 0.55% |
| Price to Book | 5.37 x | 20.2 x | 5 x | 5.06 x | 2.75 x | 2.5 x |
| Nbr of stocks (in thousands) | 448,000 | 448,000 | 448,000 | 477,041 | 477,041 | 531,273 |
| Reference price 2 | 9.700 | 39.29 | 9.657 | 13.14 | 8.750 | 8.010 |
| Announcement Date | 4/25/19 | 4/29/20 | 4/28/21 | 3/23/22 | 4/19/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 697.8 | 771.3 | 877.6 | 1,098 | 837.2 | 894.5 |
| EBITDA 1 | 111.3 | 155 | 170 | 286.3 | 159.2 | 146.1 |
| EBIT 1 | 62.36 | 89.74 | 100.4 | 209.2 | 86.28 | 55.84 |
| Operating Margin | 8.94% | 11.64% | 11.44% | 19.04% | 10.31% | 6.24% |
| Earnings before Tax (EBT) 1 | 52.84 | 92 | 5.497 | 174.5 | 42.94 | -49.16 |
| Net income 1 | 32.06 | 69.2 | 6.397 | 147.5 | 34.47 | -65.48 |
| Net margin | 4.59% | 8.97% | 0.73% | 13.43% | 4.12% | -7.32% |
| EPS 2 | 0.0714 | 0.1571 | 0.0143 | 0.3143 | 0.0700 | -0.1200 |
| Free Cash Flow 1 | -157.1 | -172.1 | 7.788 | -358.8 | -28.95 | 23.9 |
| FCF margin | -22.52% | -22.31% | 0.89% | -32.66% | -3.46% | 2.67% |
| FCF Conversion (EBITDA) | - | - | 4.58% | - | - | 16.36% |
| FCF Conversion (Net income) | - | - | 121.74% | - | - | - |
| Dividend per Share 2 | 0.0150 | 0.0343 | - | 0.0643 | 0.0200 | - |
| Announcement Date | 4/25/19 | 4/29/20 | 4/28/21 | 3/23/22 | 4/19/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 470 | 448 | 476 | 317 | - | 119 |
| Net Cash position 1 | - | - | - | - | 49.5 | - |
| Leverage (Debt/EBITDA) | 4.221 x | 2.893 x | 2.801 x | 1.106 x | - | 0.8117 x |
| Free Cash Flow 1 | -157 | -172 | 7.79 | -359 | -28.9 | 23.9 |
| ROE (net income / shareholders' equity) | 4.36% | 6.93% | -0.65% | 11.4% | 1.66% | -2.87% |
| ROA (Net income/ Total Assets) | 2.11% | 2.66% | 2.87% | 5.54% | 2.1% | 1.34% |
| Assets 1 | 1,522 | 2,597 | 223.1 | 2,662 | 1,642 | -4,872 |
| Book Value Per Share 2 | 1.810 | 1.950 | 1.930 | 2.600 | 3.180 | 3.200 |
| Cash Flow per Share 2 | 0.3100 | 0.3300 | 0.5400 | 0.5800 | 1.210 | 0.5100 |
| Capex 1 | 261 | 134 | 168 | 297 | 196 | 149 |
| Capex / Sales | 37.38% | 17.39% | 19.11% | 27.01% | 23.42% | 16.68% |
| Announcement Date | 4/25/19 | 4/29/20 | 4/28/21 | 3/23/22 | 4/19/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.85% | 454M | |
| -30.75% | 3.08B | |
| -15.97% | 2.53B | |
| +18.11% | 2.47B | |
| +7.78% | 2.1B | |
| -9.47% | 1.91B | |
| -0.56% | 1.51B | |
| +2.24% | 1.34B | |
| +24.32% | 1.24B | |
| +3.86% | 1.13B |
- Stock Market
- Equities
- 603222 Stock
- Financials Chimin Health Management Co., Ltd.
